Abstract
Invasive aspergillosis is a serious and often fatal infection in patients who are neutropenic or have undergone solid organ or stem cell transplantation. Delayed diagnosis and therapy may lead to poor outcomes. Diagnosis may be facilitated by a test for galactomannan antigen detection using an enzyme immunoassay. Other rapid methods for diagnosis include (1→3)-β-d-glucan determination and polymerase chain reaction. The sensitivity and specificity of galactomannan antigenemia testing in serum and bronchoalveolar lavage specimens are high in patients with hematological malignancy, neutropenia, and receipt of stem-cell transplants. False positivity can be seen with concomitant administration of some antibiotics and infection by fungi other than Aspergillus.
Similar content being viewed by others
References
Denning DW, Kibbler CC, Barnes RA (2003) British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 3(4):230–240
Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J (2005) Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 41(9):1242–1250
Wheat L (2003) Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 5(4):158–166
Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5(10):609–622
Mennink-Kersten MA, Donnelly JP, Verweij PE (2004) Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4(6):349–357
Wheat LJ (2005) Galactomannan Antigenemia Detection for Diagnosis of Invasive Aspergillosis, Part I. Clinical Microbiology Newsletter 27(7):51–57
Wheat LJ (2005) Galactomannan Antigenemia Detection for Diagnosis of Invasive Aspergillosis, Part II. Clinical Microbiology Newsletter 27(8):59–63
Stynen D, Sarfati J, Goris A, Prevost MC, Lesourd M, Kamphuis H, Darras V, Latge JP (1992) Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 60(6):2237–2245
Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, Heinen C, Crepin B, Van Eldere J, Tabouret M, Donnelly JP, Verweij PE (2007) Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 44(10):1329–1336
Pfeiffer CD, Fine JP, Safdar N (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 42(10):1417–1727
Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Ribaud P, Sulahian A (2006) Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 44(2):389–394
Racil Z, Kocmanova I, Lengerova M, Winterova J, Mayer J (2007) Intravenous PLASMA-LYTE as a Major Cause of False-Positive Results of Platelia Aspergillus Test for Galactomannan Detection in Serum. J Clin Microbiol 45(9):3141–3142
Surmont I, Stockman W (2007) Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity. J Clin Microbiol 45(4):1373
Girmenia C, Ballaro D, Martino P (2007) Contamination by cardboard particles as a cause of false-positive results for Aspergillus galactomannan enzyme immunoassays. Clin Vaccine Immunol 14(7):929
Murashige N, Kami M, Kishi Y, Fujisaki G, Tanosaki R (2005) False-positive results of Aspergillus enzyme-linked immunosorbent assays for a patient with gastrointestinal graft-versus-host disease taking a nutrient containing soybean protein. Clin Infect Dis 40(2):333–334
Mennink-Kersten MASH, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJM, Verweij PE (2005) Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity. J Clin Microbiol 43(8):3925–3931
Steinbach WJ, Addison RM, McLaughlin L, Gerrald Q, Martin PL, Driscoll T, Bentsen C, Perfect JR, Alexander BD (2007) Prospective Aspergillus Galactomannan Antigen Testing in Pediatric Hematopoietic Stem Cell Transplant Recipients. Pediatr Infect Dis J 26(7):558–564
Swanink CMA, Meis JFGM, Rijs AJMM, Donnelly JP, Verweij PE (1997) Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 35(1):257–260
Wheat LJ, Hackett E, Durkin M, Connolly P, Petraitiene R, Walsh TJ, Knox K, Hage C (2007) Histoplasmosis-Associated Cross-Reactivity in the BioRad Platelia Aspergillus Enzyme Immunoassay. Clin Vaccine Immunol 14(5):638–640
Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F, Bonnin A (2005) Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan. J Clin Microbiol 43(6):2929–2931
De Jesus M, Hackett E, Durkin M, Connolly P, Casadevall A, Petraitiene R, Walsh TJ, Wheat LJ (2007) Galactoxylomannan Does Not Exhibit Cross-Reactivity in the Platelia Aspergillus Enzyme Immunoassay. Clin Vaccine Immunol 14(5):624–627
Huang YT, Hung CC, Liao CH, Sun HY, Chang SC, Chen YC (2007) Detection of Circulating Galactomannan in Penicillium marneffei Infection and Cryptococcosis Among Patients Infected with Human Immnunodeficiency Virus. J Clin Microbiol 49(9):2858–2862
Giacchino M, Chiapello N, Bezzio S, Fagioli F, Saracco P, Alfarano A, Martini V, Cimino G, Martino P, Girmenia C (2006) Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Cross-Reactivity Caused by Invasive Geotrichum capitatum. J Clin Microbiol 44(9):3432–3434
Jarv H, Lehtmaa J, Summerbell RC, Hoekstra ES, Samson RA, Naaber P (2004) Isolation of Neosartorya pseudofischeri from blood: first hint of pulmonary Aspergillosis. J Clin Microbiol 42(2):925–928
Marr KA, Laverdiere M, Gugel A, Leisenring W (2005) Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 40(12):1762–1769
Bruno C, Minniti S, Vassanelli A, Pozzi-Mucelli R (2007) Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients. J Thorac Imaging 22(2):160–165
Reichenberger F, Habicht J, Matt P, Frei R, Solèr M, Bolliger CT, Dalquen P, Gratwohl A, Tamm M (1999) Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. bmt 24(11):1195–1199
Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der SC, Hoogsteden HC, De Marie S (2003) Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 121(3):448–457
Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA (2004) Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid. J Clin Microbiol 42(12):5517–5522
Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Rand KH, Schain D, Baz M, Nguyen MH (2007) Bronchoalveolar lavage galactomannan in the diagnosis of invasive pulmonary aspergillosis among solid organ transplant recipients. J Clin Microbiol 45:1759–1765
Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N (2007) Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients. Transplantation 83(10):1330–1336
Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Baz M, Rand KH, Clancy CJ (2007) Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among non-immunocompromised hosts. J Clin Microbiol 45:2787–2792
Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E (2008) Galactomannan in broncho-alveolar lavage fluid: a tool for diagnosing Aspergillosis in ICU patients. Am J Respir Crit Care Med 177:27–34
Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, Ribaud P (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease. Clinical Infectious Diseases 34(7):939–943
Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latge JP, Vilmer E (1996) Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 15(2):232–237
Salonen J, Lehtonen OP, Terasjarvi MR, Nikoskelainen J (2000) Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand J Infect Dis 32(5):485–490
Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie E (2007) Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Can 110(4):830–834
Miceli MH, Maertens J, Buve K, Grazziutti M, Woods G, Rahman M, Barlogie B, Anaissie EJ (2007) Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Can 110(1):112–120
El Saleeby CM, Allison KJ, Knapp KM, Walsh TJ, Hayden RT (2005) Discordant rise in galactomannan antigenemia in a patient with resolving Aspergillosis, renal failure, and ongoing hemodialysis. J Clin Microbiol 43(7):3560–3563
Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka KI, Ishikawa N, Hara K (1995) Plasma (1–>3)-b-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 33:3115–3118
Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S (2004) Prospective Comparison of the diagnostic potential of real-time PCR, duble-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1->3)-{beta}-D-Glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 42(6):2733–2741
Pazos C, Ponton J, Palacio AD (2005) Contribution of (1->3)-{beta}-D-Glucan Chromogenic Assay to Diagnosis and Therapeutic Monitoring of Invasive Aspergillosis in Neutropenic Adult Patients: a Comparison with Serial Screening for Circulating Galactomannan. J Clin Microbiol 43(1):299–305
Pickering JW, Sant HW, Bowles CAP, Roberts WL, Woods GL (2005) Evaluation of a (1->3)-{beta}-D-Glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43(12):5957–5962
Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10(5):882–885
Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR (2006) Reactivity of (1–>3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 50(10):3450–3453
Wheat LJ (2006) Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 8(3):128–139
Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA, Wilhelm S, Reuter S, Kern W, Sudhoff T, Morz H, Hehlmann R (2004) Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 125(2):196–202
White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA (2006) The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 42(4):479–486
Conflict of interest statement
Dr. Wheat is the President of MiraVista Diagnostics, a company that performs the Platelia® Aspergillus EIA as a commercial service, and has served as a consultant to BioRad Laboratories, the manufacturer of the test.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wheat, L.J., Walsh, T.J. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 27, 245–251 (2008). https://doi.org/10.1007/s10096-007-0437-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0437-7